Global TB Diagnostic Market Growth (Status and Outlook) 2023-2029

Global TB Diagnostic Market Growth (Status and Outlook) 2023-2029

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

LPI (LP Information)' newest research report, the “TB Diagnostic Industry Forecast” looks at past sales and reviews total world TB Diagnostic sales in 2022, providing a comprehensive analysis by region and market sector of projected TB Diagnostic sales for 2023 through 2029. With TB Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TB Diagnostic industry.

This Insight Report provides a comprehensive analysis of the global TB Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TB Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TB Diagnostic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TB Diagnostic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TB Diagnostic.

The global TB Diagnostic market size is projected to grow from US$ 2572.8 million in 2022 to US$ 3256.4 million in 2029; it is expected to grow at a CAGR of 3.4% from 2023 to 2029.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.

This report presents a comprehensive overview, market shares, and growth opportunities of TB Diagnostic market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Radiographic Method
Diagnostic Laboratory Methods
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Others

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Abbott
Becton Dickinson and Company
bioMrieux
Cepheid
F. Hoffman La Roche
Hain Lifescience
Hologic Corporation
Thermo Fisher Scientific
Qiagen

Please note: The report will take approximately 2 business days to prepare and deliver.